Experience with the treatment of metastatic ovarian carcinoma.
Metastases from non-genital sites comprise about one in six of our malignant ovarian tumors. The mean age of our 24 patients with such metastases was 43.1 years and 81% had bilateral ovarian metastases. Out of the 24 patients we studied, 21 had a gastric primary. The overall survival rate was 41.7% in 6 months, 25.0% in 1 year and 12.5% in 2 years. Patients with no extraovarian metastases had a survival rate of 75.0% at 6 months, 62.5% at 1 year and 25.0% at 2 years after operation.
Shiromizu
K
K
Department of Obstetrics and Gynecology, University of Tokyo, Japan.
Kawana
T
T
Sugase
M
M
Izumi
R
R
Mizuno
M
M
D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D011379:Prognosis